KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Gains from Investment Securities: 2017-2025

Historic Gains from Investment Securities for Twist Bioscience (TWST) over the last 9 years, with Sep 2025 value amounting to -$2.2 million.

  • Twist Bioscience's Gains from Investment Securities was N/A to -$240,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.2 million, marking a year-over-year change of. This contributed to the annual value of -$2.2 million for FY2025, which is 95.10% up from last year.
  • According to the latest figures from FY2025, Twist Bioscience's Gains from Investment Securities is -$2.2 million, which was up 95.10% from -$44.9 million recorded in FY2024.
  • Twist Bioscience's 5-year Gains from Investment Securities high stood at $33.6 million for FY2021, and its period low was -$44.9 million during FY2024.
  • For the 3-year period, Twist Bioscience's Gains from Investment Securities averaged around -$18.0 million, with its median value being -$6.8 million (2023).
  • As far as peak fluctuations go, Twist Bioscience's Gains from Investment Securities skyrocketed by 804.17% in 2021, and later crashed by 562.20% in 2024.
  • Twist Bioscience's Gains from Investment Securities (Yearly) stood at $33.6 million in 2021, then plummeted by 36.44% to $21.4 million in 2022, then tumbled by 131.75% to -$6.8 million in 2023, then crashed by 562.20% to -$44.9 million in 2024, then soared by 95.10% to -$2.2 million in 2025.